LWM
GBT

Liberty Wealth Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Liberty Wealth Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-80
Closed -$2K – 1199
2021
Q3 		$2K Hold
80
– – ﹤0.01% 1090
2021
Q2 		$3K Hold
80
– – ﹤0.01% 888
2021
Q1 		$3K Hold
80
– – ﹤0.01% 793
2020
Q4 		$3K Hold
80
– – ﹤0.01% 789
2020
Q3 		$4K Hold
80
– – ﹤0.01% 683
2020
Q2 		$5K Buy
+80
New +$5.49K ﹤0.01% 632

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Liberty Wealth Management's GBT Position: Q4 2021 in Review

Liberty Wealth Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2021, closing a stake of 80 shares — an estimated $2K sold.

Liberty Wealth Management first reported a position in GBT in Q2 2020 and held it in 6 quarters. The position peaked at $5K in Q2 2020. 206 funds tracked by Wall St. Rank hold GBT as of Q4 2021.

  • Liberty Wealth Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Liberty Wealth Management sold 80 Global Blood Therapeutics, Inc. shares in Q4 2021, an estimated $2K.
  • Liberty Wealth Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 6 quarters.
  • Liberty Wealth Management's Global Blood Therapeutics, Inc. position peaked at $5K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.